These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22212198)

  • 1. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol.
    Lacroix R; Judicone C; Poncelet P; Robert S; Arnaud L; Sampol J; Dignat-George F
    J Thromb Haemost; 2012 Mar; 10(3):437-46. PubMed ID: 22212198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.
    Owen BA; Xue A; Heit JA; Owen WG
    Thromb Res; 2011 Jan; 127(1):39-46. PubMed ID: 21106230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.
    Marchetti M; Tartari CJ; Russo L; Panova-Noeva M; Leuzzi A; Rambaldi A; Finazzi G; Woodhams B; Falanga A
    Am J Hematol; 2014 Jan; 89(1):68-73. PubMed ID: 24009132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sample processing on the measurement of circulating microparticles: storage and centrifugation parameters.
    Vila-Liante V; Sánchez-López V; Martínez-Sales V; Ramón-Nuñez LA; Arellano-Orden E; Cano-Ruiz A; Rodríguez-Martorell FJ; Gao L; Otero-Candelera R
    Clin Chem Lab Med; 2016 Nov; 54(11):1759-1767. PubMed ID: 27155005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
    Christersson C; Johnell M; Siegbahn A
    Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay.
    Hellum M; Øvstebø R; Trøseid AM; Berg JP; Brandtzaeg P; Henriksson CE
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):520-6. PubMed ID: 22732249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application.
    Douxfils J; Morimont L; Bouvy C; de Saint-Hubert M; Devalet B; Devroye C; Dincq AS; Dogné JM; Guldenpfennig M; Baudar J; Larock AS; Lessire S; Mullier F
    J Thromb Haemost; 2019 Aug; 17(8):1273-1287. PubMed ID: 31063645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.
    Lee RD; Barcel DA; Williams JC; Wang JG; Boles JC; Manly DA; Key NS; Mackman N
    Thromb Res; 2012 Jan; 129(1):80-5. PubMed ID: 21737126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
    Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
    J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy.
    Van Aalderen MC; Trappenburg MC; Van Schilfgaarde M; Molenaar PJ; Ten Cate H; Terpstra WE; Leyte A
    J Thromb Haemost; 2011 Jan; 9(1):223-6. PubMed ID: 21040450
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia.
    Campello E; Spiezia L; Radu CM; Dhima S; Visentin S; Valle FD; Tormene D; Woodhams B; Cosmi E; Simioni P
    Thromb Res; 2015 Aug; 136(2):427-31. PubMed ID: 26037284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between platelet-derived microparticle enumeration by flow cytometry and phospholipid-dependent procoagulant activity in microparticles: the centrifugation step matters!
    Stagnara J; Garnache Ottou F; Angelot F; Mourey G; Seilles E; Biichlé S; Saas P; Racadot E
    Thromb Haemost; 2012 Jun; 107(6):1185-7. PubMed ID: 22476436
    [No Abstract]   [Full Text] [Related]  

  • 14. A simple clot based assay for detection of procoagulant cell-derived microparticles.
    Patil R; Ghosh K; Shetty S
    Clin Chem Lab Med; 2016 May; 54(5):799-803. PubMed ID: 26516932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlative analysis of nanoparticle tracking, flow cytometric and functional measurements for circulating microvesicles in normal subjects.
    Enjeti AK; Ariyarajah A; D'Crus A; Seldon M; Lincz LF
    Thromb Res; 2016 Sep; 145():18-23. PubMed ID: 27429418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of centrifugation on thrombin generation in healthy subjects and in patients treated with direct oral anticoagulants.
    Hardy M; Dellanoce C; Douxfils J; Carlo A; Lessire S; Bouvy C; Testa S; Mullier F
    Int J Lab Hematol; 2021 Dec; 43(6):1585-1592. PubMed ID: 34252264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carryover of clot activators on coagulation tests during phlebotomy.
    Fukugawa Y; Ohnishi H; Ishii T; Tanouchi A; Sano J; Miyawaki H; Kishino T; Ohtsuka K; Yoshino H; Watanabe T
    Am J Clin Pathol; 2012 Jun; 137(6):900-3. PubMed ID: 22586048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased phosphatidylserine-exposing microparticles and their originating cells are associated with the coagulation process in patients with IgA nephropathy.
    He Z; Zhang Y; Cao M; Ma R; Meng H; Yao Z; Zhao L; Liu Y; Wu X; Deng R; Dong Z; Bi Y; Kou J; Novakovic V; Shi J; Hao L
    Nephrol Dial Transplant; 2016 May; 31(5):747-59. PubMed ID: 26673909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.
    Ayers L; Kohler M; Harrison P; Sargent I; Dragovic R; Schaap M; Nieuwland R; Brooks SA; Ferry B
    Thromb Res; 2011 Apr; 127(4):370-7. PubMed ID: 21257195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
    Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
    J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.